
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Calyx has announced the availability of Calyx CTMS v15.0, a trial management system aiming to reduce risk and improving efficiencies in clinical development.
Some of the features of CTMS v15.0 enable trial sponsors to:
For more information, click






